Product Information
Name:GNE 049
Brand:Biosynth
Description:GNE 049 is a monoclonal antibody that targets acetylcholine receptors. It has been shown to be effective in treating lymphocytic leukemia in mice and human cells in culture. GNE 049 is also effective against some cancers, including pancreatic cancer, colon cancer, and breast cancer. GNE 049 binds to acetylated lysine residues on histones H3 and H4. This binding inhibits the acetylation of H3 and H4, which prevents the transcription of genes that regulate cellular growth. In addition, GNE 049 has been found to inhibit the synthesis of proteins involved in inflammation, such as IL-6 and TNF-α. Clinical trials are currently underway to determine if GNE 049 will be an effective treatment for other types of cancer.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:510.58 g/mol
Formula:C27H32F2N6O2
Purity:Min. 95%
Technical inquiry about: GNE 049
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.